In addition to the mTOR pathway, E-cadherin was altered in tumors, and Kim et al. (2007) [102] suggested that β-lapachone inhibits the progression and metastasis of hepatocellular carcinoma by increasing the expression of this protein and other proteins of the mTOR pathway. Here, MTOR is linked to hepatocellular carcinoma.